PT87542B - Processo de preparacao de um medicamento a base de derivados da indolona para o tratamento da doenca de parkinson - Google Patents

Processo de preparacao de um medicamento a base de derivados da indolona para o tratamento da doenca de parkinson Download PDF

Info

Publication number
PT87542B
PT87542B PT87542A PT8754288A PT87542B PT 87542 B PT87542 B PT 87542B PT 87542 A PT87542 A PT 87542A PT 8754288 A PT8754288 A PT 8754288A PT 87542 B PT87542 B PT 87542B
Authority
PT
Portugal
Prior art keywords
compound
treatment
parkinson
activity
hydrogen
Prior art date
Application number
PT87542A
Other languages
English (en)
Portuguese (pt)
Other versions
PT87542A (pt
Inventor
David Andrew Arwydd Owen
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10617727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT87542(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PT87542A publication Critical patent/PT87542A/pt
Publication of PT87542B publication Critical patent/PT87542B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT87542A 1987-05-21 1988-05-20 Processo de preparacao de um medicamento a base de derivados da indolona para o tratamento da doenca de parkinson PT87542B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712073A GB8712073D0 (en) 1987-05-21 1987-05-21 Medicament

Publications (2)

Publication Number Publication Date
PT87542A PT87542A (pt) 1989-05-31
PT87542B true PT87542B (pt) 1992-09-30

Family

ID=10617727

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87542A PT87542B (pt) 1987-05-21 1988-05-20 Processo de preparacao de um medicamento a base de derivados da indolona para o tratamento da doenca de parkinson

Country Status (21)

Country Link
US (2) US4824860A (nl)
EP (1) EP0299602B1 (nl)
JP (1) JPH062672B2 (nl)
AT (1) ATE83659T1 (nl)
AU (1) AU599792B2 (nl)
CA (1) CA1305421C (nl)
DE (1) DE3876877T2 (nl)
DK (1) DK169609B1 (nl)
ES (1) ES2052717T3 (nl)
GB (1) GB8712073D0 (nl)
GR (1) GR3007251T3 (nl)
HK (1) HK1000913A1 (nl)
HU (1) HU201871B (nl)
IE (1) IE63511B1 (nl)
LU (1) LU90098I2 (nl)
MX (1) MX9203543A (nl)
NL (1) NL970006I2 (nl)
NZ (1) NZ224709A (nl)
PH (1) PH23867A (nl)
PT (1) PT87542B (nl)
ZA (1) ZA883602B (nl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
EP0641202A1 (en) * 1992-05-18 1995-03-08 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
GB9511366D0 (en) * 1995-06-06 1995-08-02 Smithkline Beecham Plc Novel formulations
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9612752D0 (en) * 1996-06-19 1996-08-21 Smithkline Beecham Plc Novel treatment
EP0923551B1 (en) * 1996-08-27 2002-06-05 American Home Products Corporation 4-aminoethoxy indolone derivatives
EP1073636A1 (en) * 1998-04-13 2001-02-07 American Home Products Corporation 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
US6176242B1 (en) 1999-04-30 2001-01-23 Medtronic Inc Method of treating manic depression by brain infusion
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6277875B1 (en) * 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US7858602B2 (en) * 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
US6871098B2 (en) * 2000-10-30 2005-03-22 Medtronic, Inc. Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
EP1545546B1 (en) * 2002-09-13 2007-04-04 Motac Neuroscience Limited Treatment of dyskinesia with 2,3-benzodiazepines
DE60313474T2 (de) * 2002-09-17 2008-01-03 Motac Neuroscience Ltd. Behandlung von dyskinesie
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
US20050250803A1 (en) * 2003-11-26 2005-11-10 Pfizer Inc Combination of dopamine agonists and monoamine reuptake inhibitors
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
WO2007048034A2 (en) * 2005-10-21 2007-04-26 Caritas St. Elizabeth Medical Center Of Boston, Inc. Use of androgens for the treatment of parkinson' s disease
EP2010184B1 (en) 2006-04-06 2013-01-09 Nupathe Inc. Implants for the treatment of dopamine associated states
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
US20090247537A1 (en) * 2008-03-25 2009-10-01 William Dale Overfield Methods for preventing or treating bruxism using dopaminergic agents
CN101574341B (zh) * 2008-05-05 2012-12-19 北京德众万全医药科技有限公司 一种罗匹尼罗的口服固体药物组合物
WO2010023693A2 (en) * 2008-09-01 2010-03-04 Lupin Limited Novel controlled release compositions of ropinirole
EP2452677A1 (en) 2008-09-29 2012-05-16 Wockhardt Limited Extended release dosage form of ropinirole
WO2010044108A2 (en) 2008-10-17 2010-04-22 Rubicon Research Private Limited Controlled release formulations of ropinirole
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
SG184547A1 (en) 2010-04-30 2012-11-29 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
CN103476404B (zh) 2011-03-24 2017-09-29 帝国制药美国公司 包含活性剂层和活性剂转化层的透皮组合物
US9913812B2 (en) 2011-11-09 2018-03-13 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
JP6050896B2 (ja) 2012-11-02 2016-12-21 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダン経皮組成物
US20150313891A1 (en) * 2014-05-02 2015-11-05 Abbvie Inc. Neuronal nicotinic agonists and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588740A (en) * 1982-12-07 1986-05-13 Smithkline Beckman Corporation Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones

Also Published As

Publication number Publication date
ES2052717T3 (es) 1994-07-16
US4912126A (en) 1990-03-27
HK1000913A1 (en) 1998-05-08
EP0299602A3 (en) 1990-06-06
DE3876877T2 (de) 1993-04-29
HUT47217A (en) 1989-02-28
NL970006I1 (nl) 1997-04-01
CA1305421C (en) 1992-07-21
PH23867A (en) 1989-11-23
NL970006I2 (nl) 1997-10-01
JPS63303966A (ja) 1988-12-12
GR3007251T3 (nl) 1993-07-30
JPH062672B2 (ja) 1994-01-12
MX9203543A (es) 1992-07-01
GB8712073D0 (en) 1987-06-24
US4824860A (en) 1989-04-25
IE881469L (en) 1988-11-21
DK275488D0 (da) 1988-05-19
IE63511B1 (en) 1995-05-03
HU201871B (en) 1991-01-28
AU599792B2 (en) 1990-07-26
LU90098I2 (fr) 1997-09-25
DK275488A (da) 1988-11-22
EP0299602B1 (en) 1992-12-23
EP0299602A2 (en) 1989-01-18
DE3876877D1 (de) 1993-02-04
ATE83659T1 (de) 1993-01-15
AU1644588A (en) 1988-11-24
PT87542A (pt) 1989-05-31
DK169609B1 (da) 1994-12-27
ZA883602B (en) 1989-04-26
NZ224709A (en) 1997-02-24

Similar Documents

Publication Publication Date Title
PT87542B (pt) Processo de preparacao de um medicamento a base de derivados da indolona para o tratamento da doenca de parkinson
Gaddum et al. Some central actions of 5-hydroxytryptamine and various antagonists
ES2236185T3 (es) Una composicion farmaceutica para el tratamiento del dolor agudo, cronico y/o neuropatico y migrañas.
CN104662007B (zh) 胱硫醚‑γ‑裂合酶(CSE)抑制剂
ES2335067T3 (es) Uso de duloxetina en el tratamiento de la fibromialgia.
BR0104228A (pt) Derivados do ácido de alquilamino úteis como agentes farmacêuticos, método para fabricação de um composto, composição farmacêutica, métodos para tratamentos diversos e uso de um composto na fabricação de um medicamento para tratamentos diversos
PT980246E (pt) Terapia para a obstipação
PT95564B (pt) Processo para a preparacao de (+)-ibuprofen-d-aminoacido uteis como analgesicos intensificados de ataque acelerado
AU2012210652A1 (en) Use of nicotinic acetylcholine receptor alpha 7 activators
BRPI0707557A2 (pt) neurogÊnese medida por derivado de 4-acilaminopiridina
Keegan Muscle relaxants and neuromuscular blockade
PT89036B (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de ergolina
Korsgaard et al. The Effect of Tetrahydroisoxazolopyridinol (THIP) in Tardive Dyskinesia: A New β-Aminobutyric Acid Agonist
KR20090033871A (ko) 비페프루녹스 및 ｌ-ｄｏｐａ를 포함하는 병용 제제
US6284771B1 (en) Method for treating schizophrenia
CA2362918A1 (en) Methods and compositions for treating erectile dysfunction
ES2262322T3 (es) Tratamiento de la degenaracion espinocereberal y comoposiciones utiles para el tratamiento de degeneracion espinocerebelar.
Weiner et al. Dopaminergic antagonism of L‐5‐hydroxytryptophan‐induced myoclonic jumping behavior
BR112019014529A2 (pt) Agonista de ppargama para tratamento de doença de huntington
US20220401366A1 (en) Long acting nmda antagonists
PT1539135E (pt) Tratamento da discinesia.
CA1285880C (en) Use of terguride as a geriatric agent
Bloss et al. Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat
EP3737378A1 (en) Palonosetron for the treatment or prevention of nausea and vomiting
JPH11503721A (ja) ベンズアミド誘導体の新規用途

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920311

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080520